November 3, 2015
Over the last two years, big pharma has gotten behind the idea of smartphone-connected inhalers for asthma and COPD in a big way. Two acquisitions, a $3 million investment, and a number of pilot and partnership deals have shown clearly that the space is of interest. (MobiHealthNews is helping to put on two pharma-related events at the mHealth Summit next week -- be sure to join us if you'll be in...
June 2, 2014
New Zealand-based medical device company Nexus6 has received FDA clearance for its smartphone-connected inhaler, SmartTouch, as a class II medical device. The new SmartTouch device has been cleared as a prescribable Metered Dose Inhaler (MDI) with a handful of intended uses: in clinical trials; in clinical practice, and for patient self-management.
In all cases the device is used to help track...
April 17, 2014
The Inspiromatic inhaler.
Biopharmaceutical company Opko Health has acquired Israeli smart inhaler company Inspiro Medical for a sum in "the low eight figures", according to Opko's Director of Strategic Investment Les Funtleyder. The company will be using Inspiro's Inspiromatic technology to develop an app-connected inhaler that will be bundled with a forthcoming new drug for asthma, COPD, and...